We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
SRU Biosystems Announces Issuance of 20th Patent in the Field of Label-Free Optical Biosensors and Instrumentation
News

SRU Biosystems Announces Issuance of 20th Patent in the Field of Label-Free Optical Biosensors and Instrumentation

SRU Biosystems Announces Issuance of 20th Patent in the Field of Label-Free Optical Biosensors and Instrumentation
News

SRU Biosystems Announces Issuance of 20th Patent in the Field of Label-Free Optical Biosensors and Instrumentation

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "SRU Biosystems Announces Issuance of 20th Patent in the Field of Label-Free Optical Biosensors and Instrumentation"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

SRU Biosystems has announced the issuance of their 20th patent in the field of label-free optical biosensors and instrumentation. The patent, US 7,264,973, includes claims specifically covering the label-free detection of cells on the Company’s optical biosensor.

The patent adds to the expansive coverage that the Company has secured for its core technologies, including its instrumentation, microplate designs, and product applications.

“The issuance of the 20th patent, with an additional 7 patent applications that have been allowed, is part our ongoing strategy for the Company to protect its broad intellectual property in the field of optical biosensors,” said Richard Wagner, President and CEO of SRU Biosystems.

“As part of our portfolio management, we will continue to seek worldwide protection for our innovative inventions in this exciting area.”

The patent is related to the SRU BIND® technology, including instrumentation, such as the BIND® Reader, capable of 96- and 384-well microplate detection.

The SRU BIND® Reader can be integrated into automated systems and represents solutions for antibody and small molecule/fragment screening, and cell-based applications.

Advertisement